Stock data
Eli Lilly and Company (LLY)
Eli Lilly and Company (LLY) reported revenue of US$65.18B and net income of US$20.64B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$65.18B | — | — | US$20.64B | — |
| 2024 | US$45.04B | — | — | US$10.59B | — |
| 2023 | US$34.12B | — | — | US$5.24B | — |
| 2022 | US$28.54B | — | — | US$6.24B | — |
| 2021 | US$28.32B | — | — | US$5.58B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$22.97B | US$7.09B | — |
| 2026-03-31 | US$19.80B | US$7.40B | — |
| 2025-12-31 | US$19.29B | US$6.64B | — |
| 2025-09-30 | US$17.60B | US$5.58B | — |
| 2025-06-30 | US$15.56B | US$5.66B | — |
| 2025-03-31 | US$12.73B | US$2.76B | — |
| 2024-12-31 | US$13.53B | US$4.41B | — |
| 2024-09-30 | US$11.44B | US$970.30M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.